KMT2A and leukemia: We speculate that BM-residing dendritic cells, which have the potential to induce efficient adaptive immune responses even in the absence of secondary lymphoid organs [42], might take up antigens derived from leukemia cells and induce an adaptive immune response in the MLL/AF9 leukemia model.